Losartan/Hydrochlorothiazide Excels High-dose Angiotensin Receptor Blockers in Lowering Morning Home Blood Pressure

Trial Profile

Losartan/Hydrochlorothiazide Excels High-dose Angiotensin Receptor Blockers in Lowering Morning Home Blood Pressure

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2012

At a glance

  • Drugs Losartan/hydrochlorothiazide (Primary) ; Angiotensin receptor antagonists; Candesartan cilexetil; Irbesartan; Losartan; Olmesartan medoxomil; Telmisartan; Valsartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top